JAAOS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Am Acad Orthop Surg, Vol 9, No 2, March/April 2001, 71-78.
© 2001 the American Academy of Orthopaedic Surgeons
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brief, A. A.
Right arrow Articles by Di Cesare, P. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brief, A. A.
Right arrow Articles by Di Cesare, P. E.

Use of Glucosamine and Chondroitin Sulfate in the Management of Osteoarthritis

Andrew A. Brief, MD, Stephen G. Maurer, MD and Paul E. Di Cesare, MD

Dr. Brief is Resident, Department of Orthopaedic Surgery, New York University–Hospital for Joint Diseases, New York, NY. Dr. Maurer is Resident, Department of Orthopaedic Surgery, New York University–Hospital for Joint Diseases. Dr. Di Cesare is Associate Professor of Orthopaedic Surgery, Musculoskeletal Research Center, New York University–Hospital for Joint Diseases.

Reprint requests: Dr. Di Cesare, Department of Orthopaedic Surgery, Musculoskeletal Research Center, New York University– Hospital for Joint Diseases, 301 East 17th Street, New York, NY 10003.

The goals of osteoarthritis therapy are to decrease pain and to maintain or improve joint function. The pharmacologic treatment of this condition has included the use of aspirin, acetaminophen, and nonsteroidal anti-inflammatory drugs. More recently, numerous studies have investigated the potential role of chondroprotective agents in repairing articular cartilage and decelerating the degenerative process. The reports of limited clinical experience with two of these agents, glucosamine and chondroitin sulfate, as well as the accompanying publicity in the popular media, have generated controversy. Advocates of these alternative modalities cite reports of progressive and gradual decline of joint pain and tenderness, improved mobility, sustained improvement after drug withdrawal, and a lack of significant toxicity associated with short-term use of these agents. Critics point out that in the great majority of the relevant clinical trials, sample sizes were small and follow-up was short-term.




This article has been cited by other articles:


Home page
 RadiologyHome page
R. Kijowski, D. G. Blankenbaker, K. W. Davis, K. Shinki, L. D. Kaplan, and A. A. De Smet
Comparison of 1.5- and 3.0-T MR Imaging for Evaluating the Articular Cartilage of the Knee Joint
Radiology, March 1, 2009; 250(3): 839 - 848.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
V. K. Audimoolam and S. Bhandari
Acute interstitial nephritis induced by glucosamine
Nephrol. Dial. Transplant., July 1, 2006; 21(7): 2031 - 2031.
[Full Text] [PDF]

Home page
 J Am Acad Orthop SurgHome page
M. Ulrich-Vinther, M. D. Maloney, E. M. Schwarz, R. Rosier, and R. J. O'Keefe
Articular Cartilage Biology
J. Am. Acad. Ortho. Surg., November 1, 2003; 11(6): 421 - 430.
[Abstract] [Full Text] [PDF]

Home page
 J Am Acad Orthop SurgHome page
E. L. Arnold, W. J. Arnold, A. A. Brief, S. G. Maurer, and P. E. Di Cesare
Use of Glucosamine and Chondroitin Sulfate in the Management of Osteoarthritis
J. Am. Acad. Ortho. Surg., September 1, 2001; 9(5): 352 - 353.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Academy of Orthopaedic Surgeons.